Biologics

Top Story

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
FDA News

FDA grants fast track designation to cell therapy for degenerative disk disease

August 27, 2019
The FDA has given its fast track designation to the investigational cell therapy IDCT for the treatment of degenerative disc disease. IDCT (DiscGenics) is an allogeneic…
In the Journals

More than half of patients in AS remission relapse after ceasing infliximab

April 26, 2019
Approximately 58% of patients in clinical remission after taking infliximab for ankylosing spondylitis relapse within 12 months after discontinuing the treatment…
Meeting News

Surgeon’s job with new surface technologies: Provide contact bone, achieve stable motion segments

September 27, 2018
LOS ANGELES — From the surgeon’s perspective, host bone, biologic factors and implants are key considerations when it comes to new surface materials used in…
More Headlines »
Publication Exclusive
Cover Story

Neuromodulation stem cells studied as new treatments for patients with spinal cord injuries

Spine Surgery Today, September/October 2015
An acute spinal cord injury is a sudden injury that results in a bruise, partial injury or complete injury of the…
More »
Video
Meeting News

VIDEO: Addition of silicon nitride particles reduce live bacteria in PEEK implants

November 2, 2017
More »
Video
Meeting News

VIDEO: Schroeder discusses riluzole for bone formation in patients with spinal cord injuries

November 2, 2016
More »